ACTRN12610000904077已完成未知
A randomised controlled trial of a fully automated online mindfulness-based intervention used by people with problematic alcohol use
Swinburne eTherapy Unit and National eTherapy Centre0 个研究点目标入组 74 人开始时间: 2010年10月25日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 74
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Prevention
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Participants will be aged 18 years or over and will obtain a score of 8 or higher on the Alcohol Use Disorders Identification Test (AUDIT).
排除标准
- •People under the age of 18 years and those scoring 7 or lower on the Alcohol Use Disorders Identification Test (AUDIT) will be excluded.
- •This is a open-access health promotion wellbeing program, not designed to 'treat' any condition. Nor are we targeting people or assessing for alcohol abuse/dependence disorders. Therefore we cannot confirm that participants will be healthy.
研究者
相似试验
进行中（未招募）
1 期
A phase 3 study of parsaclisib plus ruxolitinib in patients with myelofibrosismyelofibrosisMedDRA version: 20.0Level: PTClassification code 10028537Term: MyelofibrosisSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2020-003415-98-HUIncyte Corporation212
进行中（未招募）
1 期
An Efficacy and Safety Study of Alirocumab in Children and Adolescents with Heterozygous Familial HypercholesterolemiaEUCTR2017-001903-60-DESanofi-aventis recherche & développement500
进行中（未招募）
1 期
A Randomized, Double-Blind, Placebo-Controlled Study to Explore the Efficacy and Safety of Risperidone Long-Acting Intramuscular Injectable in the Prevention of Mood Episodes in Bipolar I Disorder, with Open-Label ExtensioBIPOLAR MANIAEUCTR2004-003781-14-ESJohnson and Johnson Pharmaceutical Research and Development, una división de Janssen-Cilag, S.A
进行中（未招募）
1 期
A Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First-Line Platinum-Based Chemotherapy in Subjects with Extensive Stage Small Cell Lung Cancer (MERU)Extensive Stage Small Cell Lung Cancer (ED SCLC)EUCTR2016-003503-64-GBAbbvie Deutschland GmbH & Co. KG748
进行中（未招募）
不适用
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ABT 126 in Subjects with Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase InhibitorsMedDRA version: 15.1Level: LLTClassification code 10001896Term: Alzheimer's diseaseSystem Organ Class: 100000004852Alzheimer's DiseaseEUCTR2011-004849-40-DEAbbVie Deutschland GmbH & Co. KG420